Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels

A L Slitt1, N J Cherrington, D P Hartley

  • 1Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.

Insights

Organic cation transporters (OCTs) are crucial for excreting cationic substances. This study reveals significant OCT mRNA expression in rat kidneys, highlighting their role in xenobiotic processing.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Physiology

Background:

  • Organic cation transporters (OCTs) facilitate the excretion of cationic compounds.
  • Tissue-specific OCT expression influences the disposition and elimination of xenobiotics.
  • Understanding OCT distribution is vital for predicting drug and toxin behavior.

Purpose of the Study:

  • To quantify mRNA levels of OCT1, OCT2, OCT3, OCTN1, and OCTN2 in adult rat tissues.
  • To examine the developmental expression of renal OCTs from postnatal day 0 to 45.
  • To investigate the influence of sex and gonadectomy on OCT2 expression.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) was used to measure OCT mRNA expression.
  • Analysis was performed on various adult rat tissues.
  • Kidney tissues from rats at different developmental stages (postnatal days 0-45) were analyzed.

Main Results:

  • OCT1, OCT2, OCT3, OCTN1, and OCTN2 mRNA were detected in multiple rat tissues, with prominent expression in the kidney.
  • Renal OCT1, OCTN1, and OCTN2 mRNA levels increased developmentally in both sexes.
  • Renal OCT2 expression was significantly higher in adult males, influenced by testosterone, and showed a distinct postnatal surge after day 30 in males.

Conclusions:

  • The kidney exhibits substantial expression of multiple OCT family members, underscoring its importance in handling cationic xenobiotics.
  • Developmental and sex-specific expression patterns, particularly for OCT2, suggest complex regulatory mechanisms.
  • These findings provide a foundation for understanding the renal handling of cationic drugs and endogenous compounds.

Related Concept Videos

Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...